RxDoctor Payments Data

Wardell Hollis, NP

Psychiatric/Mental Health · Alamo Heights, TXNPI 1114440195

Payments from drug & device makers

$2,906in general payments, 2019–2025

Across 167 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$661
  • AbbVie$355
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$311
  • Teva Pharmaceuticals USA, Inc.$238
  • Sunovion Pharmaceuticals Inc.$232
  • Alkermes, Inc.$211
  • plus $899 from 9 others

What the payments were for

  • Food & beverage$2,899100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,906 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$21,548
Medicare patients
35
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$197,957
VraylarCariprazine Hcl16$23,285
Lurasidone Hcl26$5,652
BelsomraSuvorexant11$4,929
Aripiprazole65$3,200
Vilazodone Hcl13$2,870
Asenapine Maleate11$2,469
Oxcarbazepine49$1,788
Duloxetine Hcl76$1,543
Clonazepam115$1,368
Quetiapine Fumarate92$1,215
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$975
Hydroxyzine Hcl29$931
Quetiapine Fumarate ErQuetiapine Fumarate35$760
Buspirone Hcl58$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$141$197,95713 claims
AbbVieVraylar$355$23,28516 claims
MerckBelsomra$71$4,92911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Alamo Heights

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →